Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aptabridge Therapeutics
Baltimore, Maryland, United Stateslinkedin.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Preclinical
01
Overview
Aptabridge Therapeutics is developing aptamer-based immune cell engagers using DNA/RNA nanoparticle technology to create highly stable, bi/multi-specific molecules for immunotherapy. Their lead program targets B-cell lymphoma, aiming to provide safer, more accessible cancer treatments by overcoming limitations of traditional bispecific antibodies. The company has received early-stage funding and recognition from Johns Hopkins University but has not yet entered clinical trials.
- Therapeutic areas
- Oncology
- Modalities
- DNA nanoparticlesRNA nanoparticlesaptamers
- Industry
- Biotech
02
Partnerships
Johns Hopkins University/FastForward U incubator support and President's Venture Fellowship funding/mentorship networkMaryland Department of Commerce sponsorship at BIO International Conference
Beyond the preview
Go deeper on Aptabridge Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aptabridge Therapeutics.